AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-187479767/diogenix-spins-off-parent.html" title="Facts and information about DioGenix spins off from parent company.">DioGenix spins off from parent company.</a>
Close
Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
Frequently asked questions about RSS feeds
DioGenix spins off from parent company.
DioGenix Inc announced its sale to Nerveda Inc, a privately held speciality pharmaceutical and diagnostic company. As consideration for acquiring all of the outstanding stock of DioGenix, Ore Pharmaceuticals Inc, the former parent company of DioGenix, received an undisclosed amount of cash, as well as a small royalty on sales of a multiple sclerosis (MS) diagnostic. Pursuant to the stock purchase agreement, Nerveda will fund DioGenix with at least $5 M to …
Related articles from newspapers, magazines, journals, and more
